Back to Results
First PageMeta Content
Pharmaceutical Benefits Scheme / Pharmaceuticals policy / Pharmacology / Medical terms / Epidemiology / Newborn screening / Screening / Serotonin–norepinephrine–dopamine reuptake inhibitor / Medical prescription / Medicine / Health / Healthcare in Australia


PBAC STAKEHOLDER MEETING OUTCOME STATEMENT NITISINONE FOR TYROSINAEMIA TYPE 1 4 February 2015 Department of Health, Canberra Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), clinicians with
Add to Reading List

Document Date: 2015-03-12 23:53:04


Open Document

File Size: 62,00 KB

Share Result on Facebook
UPDATE